At the close of the previous year, Manina Medtech, a spin-off from the Vall d’Hebron Institute of Research (VHIR), secured €1.75M in funding to support the development and clinical trials of their new medical device, SEEDCHRONY. This device is positioned to advance In Vitro Fertilization (IVF) outcomes by improving embryo implantation processes. The funding round included significant investments from a consortium of…
TMRW Life Sciences, known for its automation technology in IVF labs, has announced its expansion into the United Kingdom. This strategic move introduces the company’s advanced CryoRobot Select (CRS) system to the UK market, starting with The Hewitt Fertility Centre in Liverpool. The CRS system automates the storage and management of frozen eggs and embryos, aiming to enhance safety and efficiency in…
Mosie Baby, an at-home fertility care company, has recently obtained FDA Class II clearance for its Mosie Baby Kit. This clearance positions the Mosie Baby Kit as the first and only over-the-counter option for intravaginal insemination (IVI) approved by the FDA. The kit was developed to help individuals and couples who face challenges with natural conception or for whom traditional intercourse is…
MIM Fertility, a Polish company in the field of artificial intelligence, has announced the closing of a $2M seed funding round. The investment was led by Warsaw-based venture capital investors, Tangent Line and Peleton. MIM Fertility offers solutions in infertility treatment, combining advanced artificial intelligence technologies with reproductive medicine. Their flagship products, EMBRYOAID and FOLLISCAN help experts in the identification and analysis…
Orchid, a reproductive technology company, has announced the introduction of the world’s first 30x whole genome sequencing reports for embryos. This innovation, supported by a $12M in total funding, is set to provide prospective parents with unprecedented insights into the genetic health of embryos. Orchid’s investors include Prometheus Fund, Starbloom Capital, Refactor Capital, Pebblebed, Day One Ventures, and Conviction Capital, as well…
A study published in Nature Nanotechnology has introduced a new wearable biosensor for monitoring fertility hormones, notably oestradiol, in human sweat. This device, resembling a ring and worn on the finger, offers a non-invasive alternative to traditional blood tests for hormone monitoring. The biosensor combines microfluidics, nanoelectronics, and a class of molecules known as aptamers. These aptamers, short strands of DNA or…
Fertility Mapper, a platform focusing on enhancing access to fertility services, has launched the NHS Fertility Funding Calculator. This tool is designed to simplify the process of determining eligibility for NHS-funded fertility treatment in England, addressing the often-confusing variation in regional criteria. The introduction of this calculator is timely. The fertility sector, particularly in areas like IVF and IUI treatments, is known…
Ovia Health by Labcorp (Ovia) today announced it will offer a first-of-its-kind Fertility and Family Building Benefit, providing companies and health plans a comprehensive and customizable solution to support the diverse family-building journeys of their employees and health plan members. “Compared to existing fertility point solutions that approach fertility health as a single point in time, we designed our Fertility and Family Building…
